Physician profile
Tracy Patel
NPI 1013144369
$10,206.07
in general payments reported to CMS, 2019-2025
39 companies · $1,557 in 2025
The $1,557 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,343 · 2020: $1,118 · 2021: $1,529 · 2022: $1,210 · 2023: $1,674 · 2024: $1,775 · 2025: $1,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,986 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,985.67 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,149.83 | 2019-2024 | Xarelto |
| Abbott Laboratories | $1,137.02 | 2020-2025 | Cardiomems, Jot Dx |
| Astrazeneca Pharmaceuticals LP | $1,000.46 | 2019-2025 | Wainua, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $862.19 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $678.19 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $659.45 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $590.27 | 2019-2025 | |
| Amarin Pharma, INC. | $478.67 | 2019-2023 | |
| Pfizer INC. | $459.11 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $337.29 | 2023-2024 | Optimizer, Optimizer |
| Boston Scientific Corporation | $263.56 | 2019-2024 | Watchman Flx, Watchman Access System |
| Medtronic, INC. | $236.56 | 2024-2025 | Symplicity G3, Linq II |
| Esperion Therapeutics, INC. | $202.98 | 2020-2023 | Nexletol |
| Novo Nordisk INC | $188.05 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Kowa Pharmaceuticals America, INC. | $186.52 | 2019-2024 | Livalo |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.